Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) FCF Margin (2016 - 2025)

Standard Biotools (LAB) has disclosed FCF Margin for 16 consecutive years, with 2169.83% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin rose 57050.0% to 2169.83% in Q3 2025 year-over-year; TTM through Sep 2025 was 55.83%, a 9718.0% increase, with the full-year FY2024 number at 87.03%, down 4366.0% from a year prior.
  • FCF Margin was 2169.83% for Q3 2025 at Standard Biotools, up from 72.59% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 2169.83% in Q3 2025 to a low of 170.14% in Q2 2024.
  • A 5-year average of 132.96% and a median of 60.45% in 2021 define the central range for FCF Margin.
  • Biggest YoY gain for FCF Margin was 164789bps in 2024; the steepest drop was -13340bps in 2024.
  • Standard Biotools' FCF Margin stood at 19.61% in 2021, then tumbled by -276bps to 73.78% in 2022, then surged by 32bps to 50.16% in 2023, then skyrocketed by 60bps to 19.85% in 2024, then skyrocketed by 11031bps to 2169.83% in 2025.
  • Per Business Quant, the three most recent readings for LAB's FCF Margin are 2169.83% (Q3 2025), 72.59% (Q2 2025), and 86.62% (Q1 2025).